Evidence map›Paper›PMID 12835479›Full record

ArticleThe Journal of experimental medicine2003

Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction.

Il-Whan Choi, Young-Suk Kim, Dae-Ki Kim, Jung-Hwa Choi, Kook-Heon Seo, Shun-Young Im, Keun-Sang Kwon, Myung-Shik Lee, Tai-You Ha, Hern-Ku Lee

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Dysfunctional Innate Immune Responses and Severe Dengue.Frontiers in cellular and infection microbiology · 2020
    Review
  4. Observational
  5. Review
  6. The immunology of food allergy.Journal of immunology (Baltimore, Md. : 1950) · 2014
    Review
  7. Silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-κB signaling pathway in HMC-1 human mast cells.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2013
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Il-Whan ChoiDepartment of Immunology, University National Medical School, Chonju, Chonbuk, 561-182, South Korea.
Young-Suk Kim
Dae-Ki Kim
Jung-Hwa Choi
Kook-Heon Seo
Shun-Young Im
Keun-Sang Kwon
Myung-Shik Lee
Tai-You Ha
Hern-Ku Lee
Jeonbuk National University · KRChonnam National University · KRSamsung Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anaphylaxis is a life-threatening systemic allergic reaction with the potential for a recurrent or biphasic pattern. Despite an incidence of biphasic reaction between 5 and 20%, the molecular mechanism for the reaction is unknown. Using a murine model of penicillin V-induced systemic anaphylaxis, we show an autoregulatory cascade of biphasic anaphylactic reactions. Induction of anaphylaxis caused a rapid increase in circulating platelet-activating factor (PAF) levels. In turn, the elevated PAF contributes to the early phase of anaphylaxis as well as the subsequent activation of the nuclear factor (NF)-kappaB, a crucial transcription factor regulating the expression of many proinflammatory cytokines and immunoregulatory molecules. The induction of NF-kappaB activity is accompanied by TNF-alpha production, which, in turn, promotes late phase PAF synthesis. This secondary wave of PAF production leads eventually to the late phase of anaphylactic reactions. Mast cells do not appear to be required for development of the late phase anaphylaxis. Together, this work reveals the first mechanistic basis for biphasic anaphylactic reactions and provides possible therapeutic strategies for human anaphylaxis.

Indexed as

AnaphylaxisAnimalsHematocritInterleukin-1MaleMast CellsMiceMice, Inbred C57BLNF-kappa BPhospholipases APlatelet Activating FactorTumor Necrosis Factor-alphaInterleukin-1NF-kappa BPhospholipases APlatelet Activating FactorTumor Necrosis Factor-alpha

Identifiers

PMID12835479
PMCPMC2196087
OpenAlexW1993601962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.